Why Arm Holdings Stock Soared 224.4% Through The First Half Of 2026

Arm Holdings shares surged 224.4% in H1 2026 and the company is targeting major AI-driven growth, with revenue expected to rise from $4.92B (2026) toward $25B by 2031, largely tied to its AGI CPU (including projected $15B in direct chip sales). Management projects $9 EPS in 2031, implying a >36x P/E on the stock’s ~$334 price, leading the piece to caution against buying at current valuations despite strong AI tailwinds.

Analysis

ARM’s real opportunity is not “AI chips” in the usual accelerator sense; it is becoming the low-power control layer for AI infrastructure. That matters because the first dollars of incremental AI spending often go to GPUs, but the second derivative is a bigger fleet of CPUs, networking, and orchestration silicon around them. If Arm wins that layer, beneficiaries are likely AAPL, AMZN, and META through better internal silicon economics, while NVDA is only indirectly pressured if some inference workloads migrate to cheaper CPU-centric architectures rather than expanding overall compute demand.

The market is probably capitalizing a very long-dated revenue story into today’s price. A direct-hardware pivot also changes the quality of earnings: it may improve near-term headlines but can weaken the pristine royalty model that historically justified a premium multiple, especially if it creates friction with licensees or forces Arm to spend more on product support. The most important near-term question is whether management can convert design-win rhetoric into measurable licensing revenue acceleration within the next 2-3 quarters; otherwise the stock is vulnerable to a multiple reset even if the AI narrative stays intact.

Contrarian view: the consensus may be underestimating how hard it is for a CPU architecture company to capture meaningful economics from a fragmented, power-constrained AI stack. The upside case likely plays out over 6-18 months as data-center operators optimize for watts per inference, but the stock has already discounted several years of success. The thesis breaks if ARM can show sustained royalty growth above its historical run rate and credible adoption of the AGI CPU across multiple hyperscalers; absent that, this looks more like a momentum trade than a durable fundamental rerating.

Key Decisions for Investors

• Fade strength in ARM: initiate a starter short or buy put spreads 1-3 months out, using post-rally volatility; target valuation compression if the stock fails to produce a fresh design-win catalyst. Falsifier: any quarter with clear acceleration in royalty revenue and raised multi-year guidance.
• Pair trade: short ARM / long NVDA. The risk/reward favors the name with already-validated monetization and clearer demand visibility versus the one still monetizing a narrative. Monitor relative performance if ARM keeps outperforming NVDA for 4-6 weeks on no new data.
• For a lower-beta expression, buy AAPL or AMZN on weakness versus ARM. These hyperscalers can use Arm architecture to reduce data-center power costs without needing Arm to capture the economic upside, making them secondary beneficiaries with less execution risk.
• Avoid chasing ARM into earnings/catalyst windows until there is evidence of actual chip revenue contribution, not just pipeline commentary. If the stock de-rates 15-20% on any delay in product timing, that would be the first point to reassess a tactical long.
• Watch for commentary from META/AMZN on CPU adoption and data-center power constraints over the next 1-2 quarters; if those companies prioritize internal silicon but do not specifically mention Arm, that weakens the direct monetization case for the stock.